CDK9 and esophageal adenocarcinoma: Clonogenic assay showing ≥1.1 DERSF0.1 in all but one tested esophageal adenocarcinoma cell lines suggest synergy between CDK9 inhibition and radiation in esophageal adenocarcinoma, despite possible heterogeneity across the cell lines.